Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Narrow Band UVB on E-cadherin and Integrin Alpha v Beta 1 in Non-segmental Vitiligo: A Novel Proposed Mechanism

NCT05287776 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT05287776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05287776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Narrow Band UVB on E-cadherin and Integrin Alpha v Beta 1 in Non-segmental Vitiligo: A Novel Proposed Mechanism
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2019
Completion date
December 1, 2022
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo